InvestorsHub Logo
Followers 12
Posts 2096
Boards Moderated 0
Alias Born 02/06/2004

Re: None

Thursday, 11/04/2010 12:18:05 PM

Thursday, November 04, 2010 12:18:05 PM

Post# of 359
from the 8k filed today...

On November 3, 2010, CardioGenics Holdings Inc. (the “Company”) sold 3,861,150 shares of its common stock (the “ Private Placement Shares ”) to 13 investors (the “Investor(s)”) in exchange for $1,930,575, or $0.50 per share, pursuant to subscription agreements entered into between the Company and each Investor (the “ Subscription Agreements ”). The Private Placement Shares do not have any registration rights and are subject to the rights and restrictions of Rule 144. Further, no warrants were issued in connection with the private placement. All of the securities issuances referenced above were exempt from registration under Section 4 (2) of the Securities Act of 1933, as issuances not involving a public offering.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGNH News